https://www.amcp.org/calendar/rozanolixizumab-investigational-neonatal-fc-receptor-fcrn-treatment-generalized-myasthenia-gravis
Rozanolixizumab: An Investigational Neonatal Fc Receptor (FcRn) for the Treatment of Generalized...
Generalized mysathenia gravis (gMG) is a rare, chronic, autoimmune neuromuscular disease in which the treatment landscape is rapidly evolving.
neonatal fc receptorfor therozanolixizumabinvestigationalfcrn
https://output.eyehospital.nl/en/publications/the-neonatal-fc-receptor-is-expressed-by-human-retinal-pigment-ep/
The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is...
neonatal fc receptorretinal pigment epithelialexpressedhumancells